| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
99,047 |
91,801 |
$8.26M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
26,794 |
25,740 |
$2.40M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
27,842 |
26,012 |
$2.23M |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
241 |
223 |
$20K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
270 |
252 |
$18K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,407 |
1,120 |
$10K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
642 |
540 |
$5K |
| 99201 |
|
48 |
47 |
$2K |
| 81003 |
|
2,169 |
1,695 |
$2K |
| 71046 |
Radiologic examination, chest; 2 views |
45 |
42 |
$854.63 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
310 |
218 |
$798.58 |
| 81025 |
|
259 |
201 |
$770.30 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
17 |
17 |
$696.38 |
| 99000 |
|
57 |
54 |
$130.62 |
| 83986 |
|
23 |
13 |
$7.56 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
118 |
109 |
$0.00 |